Prevalence of bleeding secondary to anticoagulation and mortality in patients with atrial fibrillation admitted with SARS-CoV-2 infection

Atrial fibrillation (AF) is common in patients admitted with severe COVID-19. However, there is limited data about the management of chronic anticoagulation therapy in these patients. We assessed the anticoagulation and incidence of major cardiovascular events in hospitalized patients with AF and CO...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Medicina clinica 2022-06, Vol.158 (12), p.569-575
Hauptverfasser:	Rubini-Costa, Ricardo, Bermúdez-Jiménez, Francisco, Rivera-López, Ricardo, Sola-García, Elena, Nagib-Raya, Hadi, Moreno-Escobar, Eduardo, López-Zúñiga, Miguel Ángel, Briones-Través, Adela, Sanz-Herrera, Francisco, Sequí-Sabater, Jose Miguel, Romero-Cabrera, Juan Luis, Maíllo-Seco, Javier, Fernández-Vázquez, Felipe, Rivadeneira-Ruiz, María, López-Valero, Lucas, Gómez-Navarro, Carlos, Aparicio-Gómez, Jose Antonio, López, Miguel Álvarez, Tercedor, Luis, Molina-Jiménez, María, Macías-Ruiz, Rosa, Jiménez-Jáimez, Juan
Format:	Artikel
Sprache:	eng
Schlagworte:	Anticoagulación Anticoagulants - adverse effects Anticoagulation Atrial fibrillation Atrial Fibrillation - complications Atrial Fibrillation - drug therapy Atrial Fibrillation - epidemiology COVID-19 COVID-19 - complications Fibrilación auricular Hemorragia mayor Hemorrhage - chemically induced Hemorrhage - epidemiology Humans Major bleeding Mortalidad Mortality Original Prevalence Retrospective Studies Risk Factors SARS-CoV-2 Thrombosis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!